Postnatal Ovary Development in the Rat:Morphologic Study and Correlation of Morphology to Neuroendocrine Parameters

Toxicologic Pathology

Volumn 43, Issue 3, 2015, Pages 343-353

  Picut, Catherine A ^a   Dixon, Darlene ^b   Simons, Michelle L ^c   Stump, Donald G ^c   Parker, George A ^a   Remick, Amera K ^a  

^a WIL Research   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c WIL RESEARCH LABORATORIES   (United States)

Author keywords

endocrine disruptors; female; ovary; postnatal development; pubertal assay; reproduction; Sprague Dawley rats

Indexed keywords

4 AMINOBUTYRIC ACID; BONE MORPHOGENETIC PROTEIN 4; CATECHOLAMINE; FIBROBLAST GROWTH FACTOR 2; FOLLITROPIN; FOLLITROPIN RECEPTOR; GLUTAMIC ACID; GONADORELIN; GONADOTROPIN; GROWTH DIFFERENTIATION FACTOR 9; INHIBIN; KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR 7; KISSPEPTIN; LEUKEMIA INHIBITORY FACTOR; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MUELLERIAN INHIBITING FACTOR; NERVE GROWTH FACTOR; NEUROKININ B; PROSTAGLANDIN E2; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; SEX HORMONE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ENCAPSULATION; CELL MATURATION; CORPUS LUTEUM; CUMULUS OOPHORUS; EMBRYO DEVELOPMENT; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLITROPIN RELEASE; GONADORELIN RELEASE; GONADOTROPIN RELEASE; GRANULOSA CELL; HYPOTHALAMUS; JUVENILE; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MESENCHYMAL STROMA CELL; NEGATIVE FEEDBACK; NEUROENDOCRINE SYSTEM; NEWBORN PERIOD; NONHUMAN; OVARY FOLLICLE; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; OVULATION; PATHOLOGIST; POSITIVE FEEDBACK; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; STEROIDOGENESIS; ZONA PELLUCIDA; AGING; ANATOMY AND HISTOLOGY; ANIMAL; BLOOD; ESTRUS; GROWTH, DEVELOPMENT AND AGING; NEUROSECRETION; NEWBORN; OVARY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

AGING; ANIMALS; ANIMALS, NEWBORN; ESTRUS; FEMALE; GONADAL STEROID HORMONES; NEUROSECRETORY SYSTEMS; OVARIAN FOLLICLE; OVARY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84930854196     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623314544380     Document Type: Article

References (29)

1. Advis J. P. Ramirez V. D. (1977). Plasma levels of LH and FSH in female rats with precocious puberty induced by hypothalamic lesions. Biol Reprod 17, 313–20.
2. Bailey G. P. Marien D. (2011). The value of juvenile animal studies “What have we learned from preclinical juvenile toxicity studies? II.” Birth Defects Res B Dev Reprod Toxicol 92, 273–91.
3. Barrow P. C. Barbellion S. Stadler J. (2011). Preclinical evaluation of juvenile toxicity. Methods Mol Biol 691, 17–35.
4. R.W., Boyce, K.-A., Dorph-Petersen, L., Lyck, H.H.G., Gundersen, Design-based stereology: Introduction to basic concepts and practical approaches for estimation of cell number, Toxicol Pathol, (2010), 38, 1011-1025
5. Byskov A. G. (1974). Does the rete ovarii act as a trigger for the onset of meiosis? Nature 252, 396–7.
6. Davis B. J. Travlos G. McShane T. (2001). Reproductive endocrinology and toxicological pathology over the life span of the female rodent. Toxicol Pathol 29, 77–83.
7. EMA (European Medicines Agency, Committee for Human Medicinal Products [CHMP]). (2008). Guideline on the need for non-clinical testing in juvenile animals of pharmaceuticals for paediatric indications, Doc. Ref. EMEA/CHMP/SWP/169215/2005, European Medicines Agency (EMA), London, UK.
8. FDA (Food and Drug Administration), United States Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), and Center for Biologics Evaluation and Research (CBER). (2000). Guidance for industry, E11 Clinical investigation of medicinal products in the pediatric population. Food and Drug Administration, Office of Training and Communications, Division of Communications Management, Drug Information Branch, Rockville, MD.
9. FDA (Food and Drug Administration), United States Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), Pharmacology and Toxicology. (2006). Guidance for industry, Nonclinical safety evaluation of pediatric drug products. Food and Drug Administration, Office of Training and Communications, Division of Drug Information, Rockville, MD.
10. Fortune J. E. (1994). Ovarian follicular growth and development in mammals. Biol Reprod 50, 225–32.
11. Hirshfield A. N. Desanti A. M. (1995). Patterns of ovarian cell proliferation in rats during the embryonic period and the first three weeks postpartum. Biol Reprod 53, 1208–21.
12. NIH (National Institutes of Health), U.S. Department of Health & Human Services, Office of Laboratory Animal Welfare. (2002). Public health service policy on humane care and use of laboratory animals. Accessed May 28, 2014, from National Institutes of Health, Office of Laboratory Animal Welfare website: http://grants.nih.gov/grants/olaw/references/phspol.htm#PublicHealthServicePolicyonHumaneCareandUseofLaboratory.
13. Ojeda S. R. Advis J. P. Andrews W. W. (1980). Neuroendocrine control of the onset of puberty in the rat. Fed Proc 39, 2365–71.
14. Ojeda S. R. Ramirez V. D. (1972). Plasma level of LH and FSH in maturing rats: Response to hemigonadectomy. Endocrinology 90, 466–72.
15. Ojeda S. R. Skinner M. K. (2006). Puberty in the rat. In Knobil and Neill’s Physiology of Reproduction (Neill J. D. Plant T. M. Pfaff D. W. Challis J. R. G. de Kretser D. M. Richards J. S. Wassarman P. M., eds.), Vol. 2, 3rd ed., pp. 2061–126. Academic Press, San Diego, CA.
16. Pedersen T. Peters H. (1968). Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil 17, 555–7.
17. Peters H. (1969). The development of the mouse ovary from birth to maturity. Acta Endocrinol (Copenh) 62, 98–116.
18. Picut C. A. Remick A. K. Asakawa M. G. Simons M. L. Parker G. A. (2014). Histologic features of prepubertal and pubertal reproductive development in female Sprague-Dawley rats. Toxicol Pathol 42, 403–13.
19. Rajah R. Glaser E. M. Hirshfield A. N. (1992). The changing architecture of the neonatal rat ovary during histogenesis. Dev Dyn 194, 177–92.
20. Raynaud J. P. Mercier-Bodard C. Baulieu E. E. (1971). Rat estradiol binding plasma protein (EBP). Steroids 18, 767–88.
21. Rivier C. Vale W. (1987). Inhibin: Measurement and role in the immature female rat. Endocrinology 120, 1688–90.
22. Sanbuissho A. Yoshida M. Hisada S. Sagami F. Kudo S. Kumazawa T. Ube M. Komatsu S. Ohno Y. (2009). Collaborative work on evaluation of ovarian toxicity by repeated-dose and fertility studies in female rats. J Toxicol Sci 34, SP1–22.
23. Schindler R. Nilsson E. Skinner M. K. (2010). Induction of ovarian primordial follicle assembly by connective tissue growth factor CTGF. PLoS One 5, e12979, 1–10.
24. Skinner M. K. (2005). Regulation of primordial follicle assembly and development. Hum Reprod Update 11, 461–71.
25. Soyal S. M. Amleh A. Dean J. (2000). FIGα, a germ cell-specific transcription factor required for ovarian follicle formation. Development 127, 4645–54.
26. Tassinari M. S. Benson K. Elayan I. Espandiari P. Davis-Bruno K. (2011). Juvenile animal studies and pediatric drug development retrospective review: Use in regulatory decisions and labeling. Birth Defects Res B Dev Reprod Toxicol 92, 261–5.
27. US EPA (U.S. Environmental Protection Agency). (2009). Endocrine disruptor screening program test guidelines (OPPTS 890.1450): Pubertal development and thyroid function in intact juvenile/peripubertal female rats, EPA Publication 740-C-09-009. Accessed January 14, 2014, from U.S. Environmental Protection Agency, Endocrine Disruptor Screening Program website. www.epa.gov/ocspp/pubs/frs/publications/Test_Guidelines/series890.htm.
28. White S. S. Ojeda S. R. (1981). Changes in ovarian luteinizing hormone and follicle-stimulating hormone receptor content and in gonadotropin-induced ornithine decarboxylase activity during prepubertal and pubertal development of the female rat. Endocrinology 109, 152–61.
29. Williams C. J. Erickson G. F. (2012). Morphology and physiology of the ovary. In Endocrinology of Female Reproduction (Rebar R., ed.). Accessed January 14, 2014, from Endotext website: http://www.endotext.org/chapter/morphology-and-physiology-of-the-ovary.